You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA Damage Repair inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

Not yet recruiting
  • Advanced Breast Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 12, 2022

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • (no location specified)
Jan 14, 2023

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers Trial in Clinuvel Investigational Site (Afamelanotide)

Recruiting
  • Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers
  • Clinuvel Investigational Site, United Kingdom
    CLINUVEL Investigational Site
Nov 9, 2022

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

Metastatic Pancreatic Cancer Trial in Barcelona, La Coruña, Santander (olaparib+durvalumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Barcelona, Spain
  • +2 more
Dec 29, 2022

Ultraviolet Rays; Injury, DNA Adduct Formation, DNA Damage, Radiation Induced Trial in Copenhagen NV (Ultraviolet radiation)

Active, not recruiting
  • Ultraviolet Rays; Injury
  • +3 more
  • Ultraviolet radiation
  • Copenhagen NV, Denmark
    Bispebjerg Hospital, Department of Dermatology
Jul 19, 2022

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • RP-3500 in combination with Olaparib
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 23, 2022

Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)

Active, not recruiting
  • Castration Resistant Prostatic Cancer
  • Metastatic Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
May 17, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

BRCA and DNA Damage Repair Genes in Blood Samples of Chinese

Recruiting
  • Pancreatic Cancer
  • Observation
  • Shanghai, Shanghai, China
    RenJiH
Nov 17, 2021

Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

Recruiting
  • Hormone Sensitive Metastatic Prostate Cancer
  • +3 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022

Advanced Cancer Trial in Belgium, France (AsiDNA)

Completed
  • Advanced Cancer
  • Bruxelles, Belgium
  • +4 more
Mar 23, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Tumor Molecular Profiling in Patients With Prostate Cancer

Completed
  • Prostate Cancer
  • Metastatic Prostate Adenocarcinoma
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Oct 17, 2022

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +113 more
Jun 28, 2022

Breast Cancer Trial in France (Main study:, Sub-study:)

Recruiting
  • Breast Cancer
  • Main study:
  • Sub-study:
  • Bordeaux, France
  • +20 more
Jan 2, 2023

Sarcoma,Soft Tissue, Sarcoma Uterus Trial in United States (Niraparib)

Recruiting
  • Sarcoma,Soft Tissue
  • Sarcoma Uterus
  • Basking Ridge, New Jersey
  • +6 more
Aug 23, 2022